AKVA group ASA
| Dividend amount: | NOK 1.00 per share |
| Announced currency: | NOK |
| Last Day Inclusive: | 6 April 2021 |
| Ex-Date: | 7 April 2021 |
| Record Date: | 8 April 2021 |
| Payment Date: | 14 April 2021 |
| Date of Approval: | 11 March 2021 |
The Board of AKVA group ASA has resolved to distribute a half-yearly dividend of NOK 1.00 per share in the form of a repayment of retained earnings.
This information is published pursuant to the requirements set out in the Continuing obligations for stock exchange listed companies.
Dated: 12 March 2021
AKVA group ASA
Web: www.akvagroup.com
CONTACTS:
| Knut Nesse | Chief Executive Officer |
| Phone: | +47 51 77 85 00 |
| Mobile: | +47 91 37 62 20 |
| E-mail: | knesse@akvagroup.com |
| Ronny Meinkøhn | Chief Financial Officer |
| Phone: | +47 51 77 85 00 |
| Mobile: | +47 98 20 67 76 |
| E-mail: | rmeinkohn@akvagroup.com |
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
